Medicare Enrolled
Dr. Miroslav Djokic, M.D.
Pulmonary Disease · Amityville, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Djokic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Djokic?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Djokic
Dr. Miroslav Djokic is a pulmonary disease specialist in Amityville, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Djokic performed 2,043 Medicare services across 1,161 unique beneficiaries.
Between the years covered by Open Payments, Dr. Djokic received a total of $6,586 from 43 pharmaceutical and/or device companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Djokic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in NY
$6,586 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,043
Medicare services
Top 21% in NY for pulmonary disease
1,161
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
494 | $167 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
433 | $62 | $110 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
308 | $95 | $170 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $70 | $120 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
107 | $59 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $97 | $170 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
76 | $45 | $95 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
74 | $31 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
73 | $46 | $105 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
72 | $6 | $60 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $126 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $126 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $98 | $210 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
22 | $65 | $370 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
15 | $110 | $215 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
12 | $28 | $135 |
| Arterial line insertion A tube is inserted into an artery through the skin to allow for blood sampling or infusion. |
11 | $35 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
0.6% medium
98.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,586
Total received (2018-2024)
Avg $941/year across 7 years
Top 25% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
363
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,496 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,049
2023
$998
2022
$710
2021
$392
2020
$367
2019
$1,290
2018
$1,778
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
GlaxoSmithKline, LLC.
$199
AstraZeneca Pharmaceuticals LP
$154
Mylan Specialty L.P.
$109
Electromed, Inc.
$68
Amgen Inc.
$51
Actelion Pharmaceuticals US, Inc.
$50
United Therapeutics Corporation
$38
Baxter Healthcare
$29
Merck Sharp & Dohme LLC
$29
Pulmonx Corporation
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
Paratek Pharmaceuticals, Inc.
$21
GENZYME CORPORATION
$20
Regeneron Healthcare Solutions, Inc.
$16
ABBVIE INC.
$16
Top 3 companies account for 53.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,156
Olympus Corporation of the Americas
$847
GlaxoSmithKline, LLC.
$736
AstraZeneca Pharmaceuticals LP
$544
Mylan Specialty L.P.
$369
Actelion Pharmaceuticals US, Inc.
$355
Sunovion Pharmaceuticals Inc.
$263
United Therapeutics Corporation
$248
Insmed, Inc.
$229
Electromed, Inc.
$203
Pulmonx Corporation
$142
Philips Electronics North America Corporation
$142
AbbVie Inc.
$107
Janssen Pharmaceuticals, Inc
$103
Genentech USA, Inc.
$96
Allergan Inc.
$91
ABBVIE INC.
$88
Baxter Healthcare
$68
Grifols USA, LLC
$66
GENZYME CORPORATION
$66
Takeda Pharmaceuticals U.S.A., Inc.
$58
Shionogi Inc
$58
Amgen Inc.
$51
Bayer HealthCare Pharmaceuticals Inc.
$43
Astellas Pharma US Inc
$40
Mallinckrodt LLC
$40
Gilead Sciences, Inc.
$36
PFIZER INC.
$35
IDORSIA PHARMACEUTICALS US INC
$33
Novartis Pharmaceuticals Corporation
$31
Merck Sharp & Dohme LLC
$29
Shire North American Group Inc
$22
Advanced Respiratory, Inc
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Paratek Pharmaceuticals, Inc.
$21
ADVANCED RESPIRATORY, INC
$20
Melinta Therapeutics, LLC
$18
Mallinckrodt Hospital Products Inc.
$18
EKOS Corporation
$17
Regeneron Healthcare Solutions, Inc.
$16
Covis Pharma GmBH
$15
CSL Behring
$13
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALVESCO · ANORO · AREXVY · AVYCAZ · Adempas · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · CRESEMBA · DALVANCE · DUPIXENT · EKOSONIC · ELIQUIS · Esbriet · FASENRA · Fetroja · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus EBUS Bronchoscopes · Perforomist · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Vabomere · WINREVAIR · Wellcentive Undiv · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
177
Per 100K population
11.6
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Djokic is a mixed practice specialist, with above-average Medicare volume (top 21% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Djokic experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Djokic performed 494 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Djokic receive payments from pharmaceutical companies?
Yes. Dr. Djokic received a total of $6,586 from 43 companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Djokic's costs compare to other pulmonary diseases in Amityville?
Dr. Djokic's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Djokic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Amityville
Browse pulmonary diseases in Amityville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology